HomeNewsBusinessAnnouncementsBafna Pharmaceuticals' appoints Company Secretary & CO
Trending Topics
Sensex Live
Meesho Share Price
Adani Green Energy Block Deal
Aequs Share Price
Gold Rate Today

Bafna Pharmaceuticals' appoints Company Secretary & CO

The Board of Directors in their meeting held on November 10, 2017 has appointed Ms. Nirmala L, as the Company Secretary and Compliance Officer of the Company with effect from October 23, 2017.

November 10, 2017 / 21:39 IST
Story continues below Advertisement
Remove Ad

The Board of Directors in their meeting held on 10 November 2017 has appointed Ms. Nirmala L, as the Company Secretary and Compliance Officer of the Company with effect from 23 October 2017.Source : BSE

Read More

first published: Nov 10, 2017 09:39 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin youtube
News
Business New Market New Stocks Income Tax Calculator Election Schedule 2024 India News Economy Mutual Funds Personal Finance IPO News Startups New USA Elections New
Features
Gold Rate Today Silver Rate Today Trending News Startups New National News MC Videos MC You Tube
Tools
SIP Calculator 2 SIP Calculator 3 SIP Calculator 1 New SIP Calculator 4
Specials
PowerYourTrade Master Your Money Game Changers
Network 18 Sites
News18 Firstpost CNN News18 CNBC TV18 Forbes History TV18
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker Fixed Deposits Fixed Deposit Comparison Fixed Income Account Aggregator
Quick Links
About Us New Contact Us Advisory Alert New Advertise with Us New Disclaimer Privacy Policy Cookie Policy Terms & Conditions Careers Financial Terms (Glossary) Analytical & Information Tool New
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.